§16-54-3. Opioid Prescription Notifications
Prior to issuing a prescription for a Schedule II opioid drug, a practitioner shall: (1) Advise the patient regarding the quantity of the Schedule II opioid drug and a patients option to fill the prescription in a lesser quantity; and
§16-54-4. Opioid Prescription Limitations
(a) When issuing a prescription for a Schedule II opioid drug to an adult patient seeking treatment in an emergency room for outpatient use, a health care practitioner may not issue a prescription for more than a four-day supply: Provided, That a prescription for a Schedule II opioid drug issued to an adult patient in […]
§16-54-5. Subsequent Prescriptions; Limitations
(a) After issuing the initial Schedule II opioid drug prescription as set forth in §16-54-4 of this code, the practitioner, after consultation with the patient, may issue a subsequent prescription for a Schedule II opioid drug to the patient if: (1) The subsequent prescription would not be deemed an initial prescription pursuant to §16-54-4 of […]
§16-52-5. Sunset
[Repealed.]
§16-53-1. Establishment of Substance Use Disorder Treatment and Recovery Services
(a) The Secretary of the Department of Health and Human Resources shall ensure that substance use disorder treatment or recovery services, or both, are made available in locations throughout the state which the department determines to be the highest priority for serving the needs of the state. (b) The secretary shall identify and allocate funds […]
§16-53-2. Establishing the Ryan Brown Addiction Prevention and Recovery Fund
The Ryan Brown Addiction Prevention and Recovery Fund is hereby created in the state treasury as a special revenue account. The fund shall be administered by the Secretary of the Department of Health and Human Resources and shall consist of all moneys made available for the purposes of this article from any source, including, but […]
§16-53-3. Rulemaking
The Secretary of the West Virginia Department of Health and Human Resources shall promulgate emergency rules pursuant to the provisions of section fifteen, article three, chapter twenty-nine-a of this code to effectuate the provisions of this article.
§16-52-4. Powers and Duties of the Coalition for Responsible Chronic Pain Management
[Repealed.]
§16-51-2. Legislative Findings
(a) The Legislature finds and declares that: (1) The process of approval for investigational drugs, biological products and devices in the United States protects future patients from premature, ineffective and unsafe medications and treatments over the long run, but the process often takes many years;
§16-51-3. Definitions
For the purposes of this article: (1) “Eligible patient” means a person who has: